We are live on ! Find out more
DIC

Deer IX & Co Portfolio holdings

AUM $971M
1-Year Est. Return 24.77%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
-24.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.11B
AUM Growth
+$988M
Cap. Flow
+$1.09B
Cap. Flow %
98.52%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
NEUE
NeueHealth
NEUE
+$1.11B

Top Sells

1
KYMR icon
Kymera Therapeutics
KYMR
+$18.5M

Sector Composition

1 Healthcare 95.76%
2 Technology 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEUE
1
DELISTED
NeueHealth
NEUE
$998M 90.34%
+808,087
New +$1.11B
KYMR icon
2
Kymera Therapeutics
KYMR
$9.52B
$59.9M 5.42%
1,235,308
-425,163
-26% -$18.5M
NCNO icon
3
nCino
NCNO
$1.96B
$46.8M 4.24%
781,250
– –

Similar funds

WAM
World Asset Management Detroit, Michigan $1.01B AUM 42.4% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
AC
Alexandria Capital Arlington, Virginia $1.08B AUM 29.48% 1-Year Est. Return
KFM
KG Funds Management New York $855M AUM 22.34% 1-Year Est. Return
OAM
Optimal Asset Management Los Altos, California $800M AUM 28.13% 1-Year Est. Return
SIM
Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return
LBD
Landsberg Bennett & Dubbaneh Punta Gorda, Florida $785M AUM 22.85% 1-Year Est. Return
FMT
First Mercantile Trust Cordova, Tennessee $755M AUM 28.15% 1-Year Est. Return

Deer IX & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Deer IX & Co held 3 positions worth $1.11B, up 847% from $117M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer IX & Co deployed $1.09B of net new capital in Q2 2021, opening 1 new position. Its largest new stake was NeueHealth: 808,087 shares worth $998M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 55% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Kymera Therapeutics, an estimated $18.5M trimmed.

  • Deer IX & Co's largest Q2 2021 buy was NeueHealth: 808,087 shares worth $998M.
  • Deer IX & Co's biggest Q2 2021 reduction was Kymera Therapeutics, cutting an estimated $18.5M.
  • Deer IX & Co's ten largest holdings make up 100% of its $1.11B portfolio in Q2 2021.
  • Deer IX & Co opened 1 new position and closed 0 in Q2 2021.
  • Deer IX & Co's portfolio value rose 847% quarter-over-quarter to $1.11B.

Based on Deer IX & Co's 13F filing for Q2 2021, filed 16 Aug 2021.